Merck

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merck and other ETFs, options, and stocks.

About MRK

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. 

CEO
Robert M. Davis
CEORobert M. Davis
Employees
72,000
Employees72,000
Headquarters
Rahway, New Jersey
HeadquartersRahway, New Jersey
Founded
1891
Founded1891
Employees
72,000
Employees72,000

MRK Key Statistics

Market cap
307.56B
Market cap307.56B
Price-Earnings ratio
848.01
Price-Earnings ratio848.01
Dividend yield
2.44%
Dividend yield2.44%
Average volume
12.88M
Average volume12.88M
High today
High today
Low today
Low today
Open price
$121.82
Open price$121.82
Volume
480.00
Volume480.00
52 Week high
$130.24
52 Week high$130.24
52 Week low
$99.14
52 Week low$99.14

MRK News

Simply Wall St 3d
Insiders At Merck Sold US$15m In Stock, Alluding To Potential Weakness

Many Merck & Co., Inc. (NYSE:MRK) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. Knowing whether insid...

Insiders At Merck Sold US$15m In Stock, Alluding To Potential Weakness
Benzinga 4d
Newly Diagnosed Cervical Cancer Patients - Merck's Blockbuster Drug Keytruda Plus Chemoradiotherapy Improves Overall Survival

Loading... Loading... Friday, Merck & Co Inc MRK announced that the Phase 3 KEYNOTE-A18 trial, also known as ENGOT-cx11/GOG-3047, of Keytruda (pembrolizumab) i...

Newly Diagnosed Cervical Cancer Patients - Merck's Blockbuster Drug Keytruda Plus Chemoradiotherapy Improves Overall Survival
Yahoo Finance 4d
Merck's KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy Significantly Improved Overall Survival (OS ... - Yahoo Finance

KEYTRUDA plus CRT is the first immunotherapy-based regimen to demonstrate a statistically significant improvement in OS in these patients RAHWAY, N.J., March 1...

Merck's KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy Significantly Improved Overall Survival (OS ... - Yahoo Finance

Analyst ratings

77%

of 30 ratings
Buy
76.7%
Hold
13.3%
Sell
10%

More MRK News

Yahoo Finance 5d
Merck Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance

In the latest trading session, Merck (MRK) closed at $120.51, marking a -1.35% move from the previous day. The stock fell short of the S&P 500, which registered...

Merck Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance
Yahoo Finance 6d
Is Trending Stock Merck & Co., Inc. a Buy Now? - Yahoo Finance

Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influenc...

Is Trending Stock Merck & Co., Inc. a Buy Now? - Yahoo Finance
Yahoo Finance 6d
Merck & Co Inc's Dividend Analysis - Yahoo Finance

Assessing the Upcoming Dividend and Historical Performance of Merck & Co Inc Merck & Co Inc (NYSE:MRK) recently announced a dividend of $0.77 per share, payabl...

Merck & Co Inc's Dividend Analysis - Yahoo Finance
Yahoo Finance 6d
Merck Announces Plans to Conduct Clinical Trials of a Novel Investigational Multi-Valent Human Papillomavirus (HPV ... - Yahoo Finance

Company reaffirms commitment to reduce the global burden of HPV-related diseases, including certain cancers RAHWAY, N.J., March 13, 2024--(BUSINESS WIRE)--Merc...

Merck Announces Plans to Conduct Clinical Trials of a Novel Investigational Multi-Valent Human Papillomavirus (HPV ... - Yahoo Finance
Reuters 6d
Merck to test single-dose regimen of HPV vaccine Gardasil 9

March 13 (Reuters) - Merck & Co said on Wednesday it plans to conduct clinical trials testing its human papillomavirus (HPV) vaccine Gardasil 9 to evaluate the...

Merck to test single-dose regimen of HPV vaccine Gardasil 9
TipRanks 7d
Moderna, Merck start two randomized trial in cancers, says RBC Capital

RBC Capital tells investors in a research note that following the start of a third potentially pivotal trial in resectable squamous cell carcinoma, two addition...

Yahoo Finance 7d
Why Moderna Stock Price Was Up 9% on Monday - Yahoo Finance

Shares of Moderna MRNA rose 8.7% on Mar 11, after a government website posted details of the initiation of a phase II/III study on mRNA-4157/V940, its investiga...

Why Moderna Stock Price Was Up 9% on Monday - Yahoo Finance
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.